AVP and preeclampsia: Pharmacologically induced models have shown that exposure to l-NAME, an inhibitor of nitric oxide synthase (NOS), or arginine vasopressin (AVP) can replicate classic maternal and fetal preeclampsia symptoms (Molnár et al., 1994; Santillan et al., 2014).